tweenvest

BlossomHill Therapeutics, Inc. (NasdaqGS: BLSM)

Health Care · Pharmaceuticals · US

$14.84

-7.94% today · -7.3% 1Y

Public summary
A free snapshot of BlossomHill Therapeutics, Inc., with figures as of Nov 15, 2026. The full analysis is in the app.Open in the app

BlossomHill Therapeutics, Inc. (NasdaqGS: BLSM) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $471.69M and employs 69 people.

Over the last twelve months the share price has lost 7.3%, trading between 12.35 and 27.99.

Tweenvest scores BlossomHill Therapeutics, Inc. across four factors: quality 48/100, value 100/100. Its strongest factor is value.

BLSM price history

Aug 7, 2026 · 16.00Weekly closes 13.50 – 25.74Nov 12, 2026 · 14.84

Key figures

Market cap
$471.69M
Revenue (TTM)
—
P/E
-15.37
EPS
-24.83
Dividend yield
—
Beta (5Y)
—
52-week high
$27.99
52-week low
$12.35
Avg volume (3M)
—
Shares outstanding
31.78M
Employees
69
Next earnings
—

About BlossomHill Therapeutics, Inc.

Blossomhill Therapeutics, Inc. is a biopharmaceutical company. It engages in the development of small molecule medicines for unmet medical needs in cancer treatment. The company was founded in June 2020 and is headquartered in San Diego, CA.

ISIN
US0951301003
Founded
2020
Listed since
Aug 7, 2026
Exchange
Nasdaq Global Select
Currency
USD
CompanyMarket capPriceDay
ScinoPharm Taiwan, Ltd.TWSE: 1789$473.28MNT$19.70+0.25%
PKU HealthCare Corp.,Ltd.SZSE: 000788$473.21MCN¥5.30-1.49%
Aquestive Therapeutics, Inc.NasdaqGM: AQST$472.59M$3.76-3.84%
Harbin Medisan Pharmaceutical Co., Ltd.SZSE: 002900$472.51MCN¥9.97-3.11%
Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd.SHSE: 600613$470.87MCN¥6.25-5.87%
Gufic Biosciences LimitedBSE: 509079$470.55MRs438.40-0.58%
Shanghai Fudan Forward S&T Co., LtdSHSE: 600624$469.17MCN¥4.61-0.22%
ChengDu ShengNuo Biotec Co.,Ltd.SHSE: 688117$469.06MCN¥14.21-2.07%

Browse every Pharmaceuticals company →